Personalized transfusions: treating the patient, not just the number

NCT ID NCT07328191

Summary

This study is for adults with advanced blood cancers (MDS or AML) who are in palliative care and need regular blood transfusions. It compares two ways to decide when to give a transfusion: the usual method based on a blood count number, versus a new method based on changes in the patient's own reported quality of life. The goal is to see if the new method can safely give fewer transfusions while keeping patients feeling as good as possible.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU de Nice

    RECRUITING

    Nice, 06000, France

    Contact

Conditions

Explore the condition pages connected to this study.